Needham & Company LLC Reiterates Hold Rating for Definitive Healthcare (NASDAQ:DH)

Definitive Healthcare (NASDAQ:DH)‘s stock had its “hold” rating reiterated by equities research analysts at Needham & Company LLC in a research report issued to clients and investors on Thursday,Benzinga reports.

Several other brokerages have also recently commented on DH. Stephens initiated coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price objective for the company. Barclays reiterated an “underweight” rating and set a $4.00 price target on shares of Definitive Healthcare in a research report on Monday, January 13th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Definitive Healthcare has a consensus rating of “Hold” and an average price target of $5.72.

Definitive Healthcare Trading Down 0.3 %

NASDAQ:DH opened at $3.94 on Thursday. Definitive Healthcare has a 1 year low of $3.19 and a 1 year high of $10.62. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The stock has a fifty day moving average price of $4.35 and a two-hundred day moving average price of $4.50. The stock has a market capitalization of $455.15 million, a price-to-earnings ratio of -1.27, a PEG ratio of 3.26 and a beta of 1.41.

Insider Transactions at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now directly owns 433,830 shares in the company, valued at $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 14.84% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company grew its stake in Definitive Healthcare by 17.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock worth $125,000 after acquiring an additional 3,332 shares during the period. Glenmede Trust Co. NA grew its position in shares of Definitive Healthcare by 41.1% in the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock valued at $82,000 after purchasing an additional 5,362 shares during the period. Nisa Investment Advisors LLC increased its stake in Definitive Healthcare by 3,652.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock valued at $29,000 after purchasing an additional 6,794 shares during the last quarter. Point72 DIFC Ltd increased its stake in Definitive Healthcare by 759.9% in the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after purchasing an additional 8,215 shares during the last quarter. Finally, SG Americas Securities LLC lifted its position in Definitive Healthcare by 44.6% during the fourth quarter. SG Americas Securities LLC now owns 27,189 shares of the company’s stock worth $112,000 after buying an additional 8,387 shares during the period. Institutional investors and hedge funds own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.